Kuen Ling Machinery Refrigerating Co., Ltd. (4527)
Market Closed
11 Aug, 05:30
TWSE 
NT$
41. 00
+0.4
+0.9852%
NT$
- Market Cap
- P/E Ratio
0.27% Div Yield
21,647 Volume
- Eps
NT$ 40.6
Previous Close Want to track 4527 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Upcoming 4527 split of 9:10 in 50 days (30 Sep 2026)
Summary
4527 closed today higher at NT$41, an increase of 0.9852% from yesterday's close, completing a monthly increase of 4.4586% or NT$1.75. Over the past 12 months, 4527 stock gained 4.8593%.
4527 pays dividends to its shareholders, with the most recent payment made on Jun 26, 2026. The next announced payment will be in In 1 month on Oct 07, 2026 for a total of NT$1.
The last earnings report, released on May 11, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Kuen Ling Machinery Refrigerating Co., Ltd. has a scheduled stock split on Sep 30, 2026 for a 9:10 split ratio, meaning every 4527 investor will receive 9.0 shares for every 10.0 existing shares.
Kuen Ling Machinery Refrigerating Co., Ltd. has completed 8 stock splits, with the recent split occurring on Aug 23, 2012.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on XMUN (EUR).
4527 Chart
Kuen Ling Machinery Refrigerating Co., Ltd. (4527) FAQ
What is the stock price today?
The current price is NT$41.00.
On which exchange is it traded?
Kuen Ling Machinery Refrigerating Co., Ltd. is listed on TWSE.
What is its stock symbol?
The ticker symbol is 4527.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.27%.
What is its market cap?
As of today, no market cap data is available.
Has Kuen Ling Machinery Refrigerating Co., Ltd. ever had a stock split?
Kuen Ling Machinery Refrigerating Co., Ltd. had 8 splits and the recent split was on Aug 23, 2012.
Kuen Ling Machinery Refrigerating Co., Ltd. Profile
| Household Products Industry | Consumer Staples Sector | Mr. Yamada Kunio CEO | TWSE Exchange | TW0004527007 ISIN |
| Japan Country | 9,144 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Rohto Pharmaceutical Co.,Ltd., originally founded as Yamada Pharmaceutical in 1899, stands today as a global provider of pharmaceutical products, cosmetics, and functional foods. Headquartered in Osaka, Japan, the company has significantly broadened its scope of operations since its name change in September 1949. Operating worldwide, Rohto delivers a diverse range of health and beauty products and services. It has successfully expanded its portfolio to include over-the-counter (OTC) pharmaceuticals, skincare items, and even contract development and manufacturing services. Further, Rohto contributes to the healthcare field through manufacturing diagnostic reagents and offering investment management services.
Products and Services
- Eye Care Products: Rohto manufactures a variety of eye care solutions, including eye drops for relief and hydration, products tailored for contact lens users, and eye washes for cleansing and comfort.
- Facial Care Products: The company's facial care range encompasses face washes, lotions, and creams designed to nourish and protect the skin, catering to different skin types and concerns.
- Medicine and Medicated Products: Offering treatments for skin ailments, Rohto also produces lip balms, sunscreens, and functional cosmetics to enhance skin health. Additionally, it provides medicines for internal conditions like digestive issues through herbal remedies.
- Regenerative Medicines: In the cutting-edge area of regenerative medicine, Rohto is exploring new treatments designed to restore function and structure to damaged tissues and organs.
- OTC Pharmaceutical Products: The company's OTC portfolio includes a wide range of products covering ophthalmic care, dermatological treatments, gastrointestinal remedies, diagnostic drugs, Chinese herbal medicines, and nutritional supplements.
- Beauty and Health Services: Rohto operates beauty counters offering professional beauty and health consultations, catering to customers' individual needs.
- Diagnostic Reagents: Beyond pharmaceuticals and cosmetics, Rohto manufactures diagnostic reagents, contributing to medical diagnostics and research.
- Contract Development and Manufacturing: Rohto provides contract services for the development and manufacturing of pharmaceutical and cosmetic products, leveraging its expansive knowledge and infrastructure to assist other businesses in the sector.
- Investment Management Services: Demonstrating its versatile business approach, Rohto also engages in investment management, supporting startups and innovations within the healthcare and beauty industries.
Contact Information
Address: 1-8-1 Tatsuminishi
Phone: 81 6 6758 1231
Website: https://www.rohto.co.jp
